Epidemiology of colorectal cancer in Turkey: A cross-sectional disease registry study (A Turkish Oncology Group trial)

dc.contributor.authorAykan, Nuri Faruk
dc.contributor.authorYalcin, Suayib
dc.contributor.authorTurhal, N. Serdar
dc.contributor.authorOzdogan, Mustafa
dc.contributor.authorDemir, Gokhan
dc.contributor.authorOzkan, Metin
dc.contributor.authorDisci, Rian
dc.date.accessioned2026-08-12T17:16:28Z
dc.date.issued2015
dc.departmentFırat Üniversitesi
dc.description.abstractBackground/Aims: This study aimed to determine the epidemiological characteristics of colorectal cancer in Turkey. Materials and Methods: In this multicenter, prospective, and cross-sectional registry study, data for 968 patients with colorectal cancer from 21 centers in 7 geographic regions were analyzed. Results: Diagnosis was colon cancer in 662 (68.4%) and rectum cancer in 306 (31.6%) patients. In total, 60.9% of patients was male; mean age was 58.9 +/- 12.6 years. Among patients, 15.0% was drinking alcohol, 17.5% was smoking, 1.5% had familial history of polyposis, 15.0% had diabetes mellitus, 1.0% had inflammatory bowel disease. Fruit and vegetable consumption was low (<3 times/week) in 35.5% and red meat consumption was high (>= 3 times/week) in 47.4% of the patients. Median time-to diagnosis was 3.0 months and 4.0 months for patients with colon and rectum cancer, respectively. Mean body mass index was >25 in all group of patients. Distal rectum (61.3%) and sigmoid colon (36.8%) were the most common locations of cancer, for rectum and colon respectively. In total, 85.6% of patients were operated; 25.8% had emergency surgery. Low anterior resection rate was 64.2% in rectum cancer. In majority (89.8%) of the patients with rectum cancer who received preoperative treatment, conventional chemo-radiotherapy regimen was given. pTNM staging at diagnosis showed that stage III and IV patients were in majority (35.9% and 29.7%, respectively). Conclusion: Colon cancer is more frequent than rectum cancer in Turkey. Colorectal cancer patients are diagnosed at later stages. Most of the cases were operated. Interregional differences for risk factors are worthwhile for evaluation in future trials.
dc.description.sponsorshipSanofi-Aventis Turkey
dc.description.sponsorshipAuthors would like to thank to the staff of Monitor Medical Research and Consulting (Istanbul, Turkey) for study operation and Sanofi-Aventis Turkey for funding the statistical analysis.
dc.identifier.doi10.5152/tjg.2015.5685
dc.identifier.endpage153
dc.identifier.issn2148-5607
dc.identifier.issue2
dc.identifier.orcid0000-0001-6681-7249
dc.identifier.orcid0000-0002-5472-3218
dc.identifier.orcid0000-0001-8825-4918
dc.identifier.orcid0000-0003-2335-3354
dc.identifier.orcid0000-0002-5569-0913
dc.identifier.pmid25835113
dc.identifier.scopus2-s2.0-84924905248
dc.identifier.scopusqualityQ3
dc.identifier.startpage145
dc.identifier.trdizinid206366
dc.identifier.urihttps://doi.org/10.5152/tjg.2015.5685
dc.identifier.urihttps://search.trdizin.gov.tr/tr/yayin/detay/206366
dc.identifier.urihttps://hdl.handle.net/11508/52299
dc.identifier.volume26
dc.identifier.wosWOS:000351643000011
dc.identifier.wosqualityQ3
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakScopus
dc.indekslendigikaynakTR-Dizin
dc.indekslendigikaynakPubMed
dc.language.isoen
dc.publisherAves
dc.relation.ispartofTurkish Journal of Gastroenterology
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı
dc.rightsinfo:eu-repo/semantics/openAccess
dc.snmzKA_WoS_20260511
dc.subjectColorectal cancer
dc.subjectepidemiology
dc.subjectrisk factors
dc.subjectTurkey
dc.titleEpidemiology of colorectal cancer in Turkey: A cross-sectional disease registry study (A Turkish Oncology Group trial)
dc.typeArticle

Dosyalar